rs28522267

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 1P and 12B. PP3BP4_StrongBP6_Very_Strong

The NM_170606.3(KMT2C):​c.2963G>T​(p.Cys988Phe) variant causes a missense change involving the alteration of a conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 0 hom., cov: 42)
Exomes 𝑓: 0.49 ( 39 hom. )
Failed GnomAD Quality Control

Consequence

KMT2C
NM_170606.3 missense

Scores

10
5
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 7.90

Publications

39 publications found
Variant links:
Genes affected
KMT2C (HGNC:13726): (lysine methyltransferase 2C) This gene is a member of the myeloid/lymphoid or mixed-lineage leukemia (MLL) family and encodes a nuclear protein with an AT hook DNA-binding domain, a DHHC-type zinc finger, six PHD-type zinc fingers, a SET domain, a post-SET domain and a RING-type zinc finger. This protein is a member of the ASC-2/NCOA6 complex (ASCOM), which possesses histone methylation activity and is involved in transcriptional coactivation. [provided by RefSeq, Jul 2008]
KMT2C Gene-Disease associations (from GenCC):
  • Kleefstra syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Illumina, Ambry Genetics, Broad Center for Mendelian Genomics
  • syndromic intellectual disability
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 9: AlphaMissense, BayesDel_noAF, Cadd, Eigen, phyloP100way_vertebrate, PrimateAI, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.008740902).
BP6
Variant 7-152229936-C-A is Benign according to our data. Variant chr7-152229936-C-A is described in ClinVar as Benign. ClinVar VariationId is 403019.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2CNM_170606.3 linkc.2963G>T p.Cys988Phe missense_variant Exon 18 of 59 ENST00000262189.11 NP_733751.2 Q8NEZ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2CENST00000262189.11 linkc.2963G>T p.Cys988Phe missense_variant Exon 18 of 59 1 NM_170606.3 ENSP00000262189.6 Q8NEZ4-1

Frequencies

GnomAD3 genomes
AF:
0.432
AC:
46723
AN:
108170
Hom.:
0
Cov.:
42
show subpopulations
Gnomad AFR
AF:
0.405
Gnomad AMI
AF:
0.486
Gnomad AMR
AF:
0.404
Gnomad ASJ
AF:
0.457
Gnomad EAS
AF:
0.343
Gnomad SAS
AF:
0.366
Gnomad FIN
AF:
0.421
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.464
Gnomad OTH
AF:
0.404
GnomAD2 exomes
AF:
0.198
AC:
27538
AN:
139298
AF XY:
0.177
show subpopulations
Gnomad AFR exome
AF:
0.161
Gnomad AMR exome
AF:
0.229
Gnomad ASJ exome
AF:
0.170
Gnomad EAS exome
AF:
0.235
Gnomad FIN exome
AF:
0.303
Gnomad NFE exome
AF:
0.183
Gnomad OTH exome
AF:
0.237
GnomAD4 exome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.488
AC:
634391
AN:
1300290
Hom.:
39
Cov.:
31
AF XY:
0.488
AC XY:
315602
AN XY:
647150
show subpopulations
African (AFR)
AF:
0.468
AC:
12567
AN:
26874
American (AMR)
AF:
0.485
AC:
18887
AN:
38962
Ashkenazi Jewish (ASJ)
AF:
0.468
AC:
9973
AN:
21292
East Asian (EAS)
AF:
0.469
AC:
14135
AN:
30134
South Asian (SAS)
AF:
0.492
AC:
38529
AN:
78332
European-Finnish (FIN)
AF:
0.479
AC:
21993
AN:
45960
Middle Eastern (MID)
AF:
0.469
AC:
1594
AN:
3400
European-Non Finnish (NFE)
AF:
0.490
AC:
492288
AN:
1004250
Other (OTH)
AF:
0.478
AC:
24425
AN:
51086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.434
Heterozygous variant carriers
0
19194
38387
57581
76774
95968
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20182
40364
60546
80728
100910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
0.432
AC:
46735
AN:
108214
Hom.:
0
Cov.:
42
AF XY:
0.431
AC XY:
23365
AN XY:
54184
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.405
AC:
10806
AN:
26694
American (AMR)
AF:
0.404
AC:
4250
AN:
10532
Ashkenazi Jewish (ASJ)
AF:
0.457
AC:
1094
AN:
2396
East Asian (EAS)
AF:
0.343
AC:
1253
AN:
3650
South Asian (SAS)
AF:
0.368
AC:
1218
AN:
3310
European-Finnish (FIN)
AF:
0.421
AC:
3226
AN:
7670
Middle Eastern (MID)
AF:
0.144
AC:
28
AN:
194
European-Non Finnish (NFE)
AF:
0.464
AC:
23872
AN:
51460
Other (OTH)
AF:
0.403
AC:
647
AN:
1606
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.325
Heterozygous variant carriers
0
2395
4790
7185
9580
11975
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
638
1276
1914
2552
3190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.361
Hom.:
6
ExAC
AF:
0.105
AC:
12517

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
1.0
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Pathogenic
0.56
CADD
Pathogenic
28
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.67
D;D
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.72
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.93
.;D
MetaRNN
Benign
0.0087
T;T
MetaSVM
Pathogenic
0.85
D
MutationAssessor
Uncertain
2.5
M;M
PhyloP100
7.9
PrimateAI
Pathogenic
0.89
D
PROVEAN
Pathogenic
-9.0
D;D
REVEL
Pathogenic
0.97
Sift
Pathogenic
0.0
D;D
Polyphen
1.0
D;D
Vest4
0.84
MPC
2.9
ClinPred
0.055
T
GERP RS
4.7
Varity_R
0.95
gMVP
0.92
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28522267; hg19: chr7-151927021; COSMIC: COSV51275056; API